Skip to main content
Chetan Bettegowda, MD, Neurosurgery, Lutherville, MD

ChetanBettegowdaMD

Neurosurgery • Lutherville, MD

Assistant Professor of Neurological Surgery, Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Bettegowda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bettegowda's full profile

Already have an account?

  • Office

    10753 Falls Road
    Pavilion II, Suite 115
    Lutherville, MD 21093
    Phone+1 410-955-6406
    Fax+1 410-616-7231

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurological Surgery, 2006 - 2012
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineInternship, Transitional Year, 2005 - 2006
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2005

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2012 - 2026
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • Neurological Surgery
    American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Subependymal Giant Cell Astrocytoma-like Astrocytoma: A Neoplasm with a Distinct Phenotype and Frequent Neurofibromatosis Type-1-Association  
    Murat Gokden, Fausto J Rodriguez, Mark Jentoft, Chetan Bettegowda, Caterina Giannini, Aditya Raghunathan, Doris Lin, Nature

Authored Content

  • The Radiographic Effects of Surgical Approach and Use of Retractors on the Brain After Anterior Cranial Fossa Meningioma ResectionJanuary 2018
  • The Radiographic Effects of Surgical Approach and Use of Retractors on the Brain After Anterior Cranial Fossa Meningioma ResectionJanuary 2018

Press Mentions

  • Experimental Blood Test Accurately Indicates Severity and Predicts Potential Recovery from Spinal Cord Injury
    Experimental Blood Test Accurately Indicates Severity and Predicts Potential Recovery from Spinal Cord InjuryMarch 31st, 2025
  • Assessing the Utilization of Palliative Care in Advanced NSCLC Patients with Brain Metastases
    Assessing the Utilization of Palliative Care in Advanced NSCLC Patients with Brain MetastasesNovember 27th, 2024
  • ESKD with Renal Artery Stenosis
    ESKD with Renal Artery StenosisNovember 25th, 2024
  • Join now to see all

Grant Support

  • Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
  • Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
  • Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
  • Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
  • Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
  • Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Cell-free DNA-Based Analysis for Diagnosis, Monitoring and Optimization of Therapy for Patients with Primary Central Nervous System LymphomasJOHNS HOPKINS UNIVERSITY2022–2025
  • Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
  • Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
  • Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
  • Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
  • Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
  • Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
  • Multi-omic CSF Assay for the Diagnosis of Brain CancersBELAY DIAGNOSTICS, LLC2024

Professional Memberships

Other Languages

  • Kannada

External Links

Dr. Chetan Bettegowda, Dr. Chetan Bettegowda, MD, Dr. C Bettegowda